291 related articles for article (PubMed ID: 7846048)
1. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.
Evans KC; Berger EP; Cho CG; Weisgraber KH; Lansbury PT
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):763-7. PubMed ID: 7846048
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
3. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD
J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342
[TBL] [Abstract][Full Text] [Related]
5. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
7. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.
Wood SJ; Chan W; Wetzel R
Biochemistry; 1996 Sep; 35(38):12623-8. PubMed ID: 8823200
[TBL] [Abstract][Full Text] [Related]
8. The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific.
Dafnis I; Argyri L; Sagnou M; Tzinia A; Tsilibary EC; Stratikos E; Chroni A
Sci Rep; 2016 Aug; 6():30654. PubMed ID: 27476701
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro.
McGeer PL; Walker DG; Pitas RE; Mahley RW; McGeer EG
Brain Res; 1997 Feb; 749(1):135-8. PubMed ID: 9070638
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
[TBL] [Abstract][Full Text] [Related]
11. Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures.
Jordán J; Galindo MF; Miller RJ; Reardon CA; Getz GS; LaDu MJ
J Neurosci; 1998 Jan; 18(1):195-204. PubMed ID: 9412500
[TBL] [Abstract][Full Text] [Related]
12. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease.
Mahley RW; Nathan BP; Pitas RE
Ann N Y Acad Sci; 1996 Jan; 777():139-45. PubMed ID: 8624076
[TBL] [Abstract][Full Text] [Related]
14. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
[TBL] [Abstract][Full Text] [Related]
15. The interaction of amyloid-beta with ApoE.
Carter DB
Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
[TBL] [Abstract][Full Text] [Related]
16. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
[TBL] [Abstract][Full Text] [Related]
17. Specific modulation of the fusogenic properties of the Alzheimer beta-amyloid peptide by apolipoprotein E isoforms.
Pillot T; Goethals M; Vanloo B; Lins L; Brasseur R; Vandekerckhove J; Rosseneu M
Eur J Biochem; 1997 Feb; 243(3):650-9. PubMed ID: 9057828
[TBL] [Abstract][Full Text] [Related]
18. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
[TBL] [Abstract][Full Text] [Related]
19. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.
Chou CY; Lin YL; Huang YC; Sheu SY; Lin TH; Tsay HJ; Chang GG; Shiao MS
Biophys J; 2005 Jan; 88(1):455-66. PubMed ID: 15475580
[TBL] [Abstract][Full Text] [Related]
20. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid.
LaDu MJ; Pederson TM; Frail DE; Reardon CA; Getz GS; Falduto MT
J Biol Chem; 1995 Apr; 270(16):9039-42. PubMed ID: 7721816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
